Evidence map›Paper›PMID 1531292›Full record

ArticleThe Biochemical journal1992

Effect of interferon-gamma on complement gene expression in different cell types.

D F Lappin, D Guc, A Hill, T McShane, K Whaley

Open access · greenAbstract read
In one paragraph

Article in The Biochemical journal, 1992. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 80 citations in OpenAlex.

  1. Frontiers in pharmacology · 2025
    Article
  2. Article
  3. Article
  4. A novel pathogenetic factor of laryngeal attack in hereditary angioedema? Involvement of protease activated receptor 1.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2022
    Article
  5. Frontiers in immunology · 2022
    Review
  6. Review
  7. Article
  8. Article
  9. Production of complement components by cells of the immune system.Clinical and experimental immunology · 2017
    Review
  10. Article
  11. The complement system: history, pathways, cascade and inhibitors.European journal of microbiology & immunology · 2012
    Review
  12. Enhanced expression of the complement factor H mRNA in proliferating human RPE cells.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2010
    Article
  13. Interferon gamma in successful pregnancies.Biology of reproduction · 2009
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Regulation of early complement components C3 and C4 in the synovium.Clinical and diagnostic laboratory immunology · 1996
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

D F LappinDepartment of Pathology, Western Infirmary, Glasgow, U.K.
D Guc
A Hill
T McShane
K Whaley
Western Infirmary · GB

Funding

Wellcome Trust
6 · The paper itself

Abstract

We have studied the expression of the complement components C2, C3, factor B, C1 inhibitor (C1-inh), C4-binding protein (C4-bp) and factor H in human peripheral blood monocytes, skin fibroblasts, umbilical vein endothelial cells (HUVEC) and the human hepatoma cell line G2 (Hep G2) in the absence and the presence of interferon-gamma (IFN-gamma). E.l.i.s.a. performed on culture fluids, run-on transcription assays, Northern blot and double-dilution dot-blot techniques confirmed that monocytes expressed all six components, whereas fibroblasts, HUVEC and HepG2 each expressed five of the six components. Fibroblasts and HUVEC did not synthesize C4-bp, and Hep G2 did not produce factor H. In addition to these differences, the synthesis rates of C3, C1-inh and factor H were not the same in all cell types. However, the synthesis rates of C2 and factor B were similar in all four cell types. The half-lives of the mRNAs were shorter in monocytes than in other cell types. Monocyte factor H mRNA had a half-life of 12 min in monocytes, compared with over 3 h in fibroblasts and HUVEC. The instability of factor H mRNA in monocytes may contribute to their low factor H secretion rate. IFN-gamma produced dose-dependent stimulation of C2, factor B, C1-inh, C4-bp and factor H synthesis by all cell types expressing these proteins, but decreased C3 synthesis in all four cell types. Cell-specific differences in the response to IFN-gamma were observed. The increased rates of transcription of the C1-inh and factor H genes in HUVEC were greater than in other cell types, while the increased rate of transcription of the C2, factor B and C1-inh genes in Hep G2 cells was less than in other cell types. IFN-gamma did not affect the stability of C3, factor H or C4 bp mRNAs, but increased the stability of factor B and C1-inh mRNAs and decreased the stability of C2 mRNA. Although these changes occurred in all four cell types studied, the half-life of C1-inh mRNA in monocytes was increased almost 4-fold, whereas the increases in the other cell types were less than 30%. These data show that the constitutive synthesis rates of complement components may vary in the different cell types. They also show that the degree of change in synthesis rates in response to IFN-gamma in each of the cell types often varies due to differences in transcriptional response, sometimes in association with changes in mRNA stability.

Indexed as

Gene Expression RegulationCarrier ProteinsCells, CulturedComplement C1 Inactivator ProteinsComplement C2Complement C3Complement C3bComplement C3b Inactivator ProteinsComplement C4Complement Factor HComplement System ProteinsHumansIntegrin alphaXbeta2Interferon-gammaKineticsOrgan SpecificityCarrier ProteinsCFH protein, humanComplement C1 Inactivator ProteinsComplement C2Complement C3Complement C3bComplement C3b Inactivator ProteinsComplement C4Complement Factor HComplement System ProteinsIntegrin alphaXbeta2Interferon-gammaRNA, Messenger

Identifiers

PMID1531292
PMCPMC1130704
OpenAlexW7411795

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.